NZ181958A - 2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions - Google Patents

2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions

Info

Publication number
NZ181958A
NZ181958A NZ181958A NZ18195876A NZ181958A NZ 181958 A NZ181958 A NZ 181958A NZ 181958 A NZ181958 A NZ 181958A NZ 18195876 A NZ18195876 A NZ 18195876A NZ 181958 A NZ181958 A NZ 181958A
Authority
NZ
New Zealand
Prior art keywords
benzophenones
triazol
substituted
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
NZ181958A
Other languages
English (en)
Inventor
T Ishiba
K Hirai
H Sugimoto
T Fujishita
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NZ181958A publication Critical patent/NZ181958A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/92Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ181958A 1975-12-30 1976-09-07 2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions NZ181958A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof

Publications (1)

Publication Number Publication Date
NZ181958A true NZ181958A (en) 1979-03-28

Family

ID=10467048

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ181958A NZ181958A (en) 1975-12-30 1976-09-07 2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions

Country Status (19)

Country Link
JP (1) JPS5283469A (en:Method)
AR (2) AR218613A1 (en:Method)
AT (1) AT350052B (en:Method)
AU (1) AU498113B2 (en:Method)
BE (1) BE846410A (en:Method)
CA (1) CA1126274A (en:Method)
CH (1) CH623315A5 (en:Method)
DE (1) DE2641164A1 (en:Method)
DK (1) DK393576A (en:Method)
ES (3) ES451896A1 (en:Method)
FR (1) FR2336930A1 (en:Method)
GB (1) GB1531980A (en:Method)
HU (1) HU172539B (en:Method)
IE (1) IE43841B1 (en:Method)
IL (1) IL50664A (en:Method)
NL (1) NL7610799A (en:Method)
NZ (1) NZ181958A (en:Method)
SE (1) SE7609813L (en:Method)
ZA (1) ZA765851B (en:Method)

Also Published As

Publication number Publication date
CH623315A5 (en) 1981-05-29
AU1749876A (en) 1978-03-16
ES462244A1 (es) 1978-06-01
IL50664A0 (en) 1976-12-31
GB1531980A (en) 1978-11-15
SE7609813L (sv) 1977-07-01
AU498113B2 (en) 1979-02-08
IE43841B1 (en) 1981-06-03
HU172539B (hu) 1978-09-28
AR220519A1 (es) 1980-11-14
ATA684276A (de) 1978-10-15
FR2336930B1 (en:Method) 1978-12-22
IL50664A (en) 1983-09-30
DE2641164A1 (de) 1977-07-14
AT350052B (de) 1979-05-10
ES462243A1 (es) 1978-06-01
ES451896A1 (es) 1978-01-16
FR2336930A1 (fr) 1977-07-29
DK393576A (da) 1977-07-01
ZA765851B (en) 1977-09-28
NL7610799A (nl) 1977-07-04
BE846410A (fr) 1977-01-17
IE43841L (en) 1977-06-30
JPS5283469A (en) 1977-07-12
CA1126274A (en) 1982-06-22
AR218613A1 (es) 1980-06-30

Similar Documents

Publication Publication Date Title
ZA7671B (en) Pharmaceutical composition
NZ186197A (en) 3,4,5-trimethoxybenzene derivatives and pharmaceutical compositions
JPS5272829A (en) Pharmaceutical composition
GR61176B (en) Pharmaceutical compositions and process for the preparation thereof
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
PH12974A (en) 6,7-benzomorphan derivatives and their pharmaceutical composition
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
NZ179835A (en) Aminoalkynoic acids,derivatives and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
NZ182502A (en) 1,4-dihydro-2,6-dimethyl-3-methoxycarbonyl-5-isobut-oxycarbonyl-4-(21-nitrophenyl)-pyridine and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NZ187825A (en) 1,2,4-oxadiazole derivatives and pharmaceutical compositions
NZ182716A (en) 4-(7-bromo-5-methoxy-2-benzofuranyl)-1,2,3,6-tetrahtdropyridine or-piperidine derivatives and pharmaceutical compositions
NZ180863A (en) 3,5-bisoxygenated 2-(w-halo-3-oxygenated-1-alkenyl)-cyclopentane-1-heptanoic acid derivatives and pharmaceutical compositions